ISBG yields 4.03% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, ISBG + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ISBG + MRK for your $10,000?
ISBG seeks total return by offering simultaneous leveraged exposure to bitcoin and gold, targeting a beta of approximately 1.0 for each. It combines the returns from both beta strategies while seeking to generate income through an options premium strategy overlay. To reach its target beta levels, the fund invests in bitcoin futures, ETFs, ETPs, and options on bitcoin indices, alongside gold futures, ETFs, ETPs, and derivatives. It uses leverage to stack the total return of its bitcoin holdings with the returns of its gold strategy. Essentially, every $1 investment is $1 exposure to bitcoin and $1 to gold. Futures contracts are rolled over regularly to maintain exposure. Collateral investments, including US Treasury bills, money market funds, and cash equivalents, typically comprise 10% to 65% of net assets. The funds realized beta generally ranges between 0.8 and 1.2 for each asset class due to fluctuations. It may also invest up to 25% in a wholly owned Cayman Islands subsidiary.
Full ISBG Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.